Cerebrolysin

Cerebrolysin is a peptide preparation derived from purified porcine brain tissue, containing a mixture of low-molecular-weight peptides and free amino acids designed to mimic the action of endogenous neurotrophic factors like BDNF, NGF, and GDNF. It is one of the most clinically studied peptide preparations in the world, with thousands of patients treated in clinical trials across Europe and Asia, primarily for stroke, dementia, and traumatic brain injury. It is approved in many countries — though not the US — and is sold elsewhere as a research preparation.

Your brain has its own growth and repair signals — proteins like BDNF (brain-derived neurotrophic factor) and NGF (nerve growth factor) that keep neurons healthy and help them recover from injury. Cerebrolysin is a complex preparation extracted from pig brains that is studied as a kind of 'neurotrophic cocktail' — a mix of small peptides and amino acids designed to mimic those repair signals. It has been used clinically for stroke recovery, Alzheimer's, and traumatic brain injury in many countries for decades.

Cerebrolysin contains short biologically active peptide fragments that cross the blood-brain barrier and mimic the action of neurotrophic factors. It is proposed to support neuronal survival, promote synaptic plasticity, modulate neuroinflammation, and protect against excitotoxic damage. In stroke models, it reduces infarct volume and supports functional recovery. In Alzheimer's research, it is studied for cognitive improvements and reduced disease progression markers.

Multi-peptide mixture from highly purified porcine brain tissue. Neuroplasticity and cognitive recovery.

1. Cerebrolysin
2. CNS receptor systems (melanocortin, BDNF, GABAergic or sleep-regulating)
3. Neurotransmitter and neurotrophic signalling
4. Cognition, mood, sleep and libido research endpoints

A plain-English read on how much published evidence currently exists for Cerebrolysin. These ratings describe the volume and maturity of the literature — not effectiveness, safety, or suitability for any use.

Current limitations: most compounds in this category are studied in preclinical or small-sample settings. Absence of large controlled human trials is the single biggest limitation to keep in mind when reading any summary of Cerebrolysin.

Lyophilized compounds are supplied as a dry powder. Concentration is simply the total amount in the vial divided by the volume of bacteriostatic water added:

Concentration (mg/mL) = total mg in vial ÷ mL of diluent added

Commonly supplied vial sizes

5mL or 10mL ampoules (215mg/mL solution)

Worked concentration example

Pre-mixed solution — no reconstitution needed.

Run your own numbers with the reconstitution calculator — it converts vial size and diluent volume into mg/mL and mcg/mL.

The figures below are reported here descriptively, because they are the values most frequently cited in publicly available research literature and reference material. They are not instructions, not a protocol, and not a recommendation. These compounds are supplied for laboratory research use only and are not approved by the FDA for human consumption.

Commonly cited amounts

5–10mL daily IM (intramuscular)

Commonly cited frequency

Daily during the course

Commonly cited study duration

10–20 day courses, several per year

Peptides are supplied freeze-dried because peptide bonds degrade far faster in solution than in a dry state. Understanding storage is part of understanding why the powder form exists at all.

• •Lyophilized powder: stored refrigerated, typically stable for months to years.
• •Reconstituted solution: refrigerated at 2–8°C, generally discussed as stable for roughly 30–60 days.
• •Heat and direct light accelerate degradation — vials are kept cool and dark.
• •Reconstituted material is not re-frozen; ice crystal formation disrupts peptide structure.
• •Bacteriostatic water contains 0.9% benzyl alcohol as a preservative, which is what allows multi-day storage after reconstitution.

More detail in the storage & handling guide and how peptide quality is evaluated.

• •Ischemic stroke recovery (multiple phase 3 trials)
• •Alzheimer's disease and vascular dementia
• •Traumatic brain injury
• •Pediatric neurodevelopmental conditions
• •ADHD and learning research
• •Neurotrophic factor mimicry

Cerebrolysin is a recurring favorite in serious nootropic forums (r/Nootropics, LongeCity) and in TBI/concussion recovery threads. Users compare it to Semax and Selank but emphasize its more 'restorative' rather than 'stimulant' character — improvements over weeks rather than the immediate noticeable effects of intranasal peptides. The protocol is more intensive: typically intramuscular injections in cycles of 5–20 days.

“A brain-repair cocktail in injectable form.”

Cerebrolysin is often run in dedicated cycles rather than open-ended stacks. When combined, it is most commonly paired with Semax (for daily focus during the cycle) or with BPC-157 (for users dealing with concurrent gut or systemic issues). It is one of the few peptides with enough clinical data that physicians outside the US sometimes prescribe it.

Cerebrolysin is a porcine brain-derived peptide preparation with extensive clinical data in stroke, dementia, and traumatic brain injury. It mimics endogenous neurotrophic factors like BDNF and NGF and is approved in many countries outside the US for neurological indications.